Industry n/a · SIC —
GSK plc
GSK
Latest revenue
—
as of —
Latest net income
—
as of —
Net margin
—
as of —
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $221.73B
- Enterprise value
- $221.73B
- P/E (trailing)
- —
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 3.4%
- 52-wk high
- $61.70
- 52-wk low
- $35.45
- Beta
- —
- Shares out
- 4.32B
5-year trend
About GSK
Business description and risk factors will appear here once GSK's latest filing is fully ingested.
Earnings tracker
Not enough quarterly history for GSK yet to draw an earnings tracker.
Industry trend
Industry · SIC —
Your notes
Keep private notes on GSK — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
No insider transactions on file for GSK in the last 12 months.
Source: SEC Form 4 filings. Backfill runs nightly.
Who owns GSK
Institutional value
$6.90B
Total shares held
139.0M
Distinct holders
796
As of
2026-03-31
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | Fisher Asset Management, LLC | 34.5M | $1.91B | — | New |
| 2 | PRIMECAP MANAGEMENT CO/CA/ | 25.2M | $1.39B | — | New |
| 3 | Mondrian Investment Partners LTD | 5.0M | $275.3M | — | New |
| 4 | BANK OF MONTREAL /CAN/ | 4.6M | $256.1M | — | New |
| 5 | BlackRock, Inc. | 3.6M | $196.0M | — | New |
| 6 | EQUITY INVESTMENT CORP | 3.2M | $177.8M | — | New |
| 7 | Connor, Clark & Lunn Investment Management Ltd. | 2.8M | $155.5M | — | New |
| 8 | DIMENSIONAL FUND ADVISORS LP | 2.6M | $142.8M | — | New |
| 9 | SEI INVESTMENTS CO | 2.3M | $126.2M | — | New |
| 10 | UBS Group AG | 2.1M | $115.0M | — | New |
| 11 | ENVESTNET ASSET MANAGEMENT INC | 1.8M | $101.4M | — | New |
| 12 | BNP PARIBAS FINANCIAL MARKETS | 1.7M | $93.7M | — | New |
| 13 | LETKO, BROSSEAU & ASSOCIATES INC | 1.6M | $90.8M | — | New |
| 14 | MILLER HOWARD INVESTMENTS INC /NY | 1.6M | $89.9M | — | New |
| 15 | CITIGROUP INC | 1.5M | $82.6M | — | New |
| 16 | WELLS FARGO & COMPANY/MN | 1.4M | $77.6M | — | New |
| 17 | Mariner, LLC | 1.2M | $67.9M | — | New |
| 18 | Russell Investments Group, Ltd. | 1.1M | $57.9M | — | New |
| 19 | Douglas Lane & Associates, LLC | 1.0M | $55.7M | — | New |
| 20 | FRANKLIN RESOURCES INC | 942.4K | $52.0M | — | New |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
Coming once GSK's latest filing finishes processing.